The Chief Epidemiologist has decided that the Moderna vaccine against Covid-19 will not be used in Iceland while further information is obtained on the safety of the vaccine during booster vaccinations.
An announcement states that in recent days there has been data from the Nordic countries on the increased incidence of myocarditis and pericarditis after vaccination with the Moderna vaccine in addition to the Pfizer / BioNTech vaccine.
According to the epidemiologist, the Moderna vaccine has for the past two months been used almost exclusively here for stimulation vaccinations after the Janssen vaccine and after two-dose vaccinations for the elderly and immunocompromised. Very few individuals are said to have received the second dose of the basic vaccine that started with Moderna.
Sufficient supply of Pfizer
In Sweden, the use of Moderna has been restricted to individuals born before 1991. In Norway and Denmark, it has been emphasized that the Pfizer vaccine is recommended rather than Moderna for 12 to 17 year olds.
In Iceland, only the Pfizer vaccine has been recommended for primary vaccination at 12 to 17 years of age since the vaccination of the age group began.
According to the Chief Epidemiologist, the decision was made to wait with the use of Moderna as there is a sufficient supply of Pfizer vaccine for booster vaccinations of defined priority groups and basic vaccinations of those who have not yet been vaccinated.
By Eiður Þór Árnason Via https://www.visir.is/g/20212167101d/stodva-notkun-boluefnis-moderna-her-a-landi-i-ljosi-nyrra-gagna